Skip to main content

Table 1 Expression of VEGF and HIF-1α in each group

From: Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma

Groups VEGF/GAPDH HIF-1α/GAPDH
Control 0.515 ± 0.002 ## 0.555 ± 0.002 ##
MTD NVB 0.547 ± 0.003 0.754 ± 0.003
Endo+MTD NVB 0.639 ± 0.004 ## 0.868 ± 0.004 ##
Endo 0.346 ± 0.001 0.382 ± 0.002
MET NVB 0.181 ± 0.001 0.201 ± 0.001
Endo+MET NVB 0.078 ± 0.001** 0.041 ± 0.001**
  1. Data are presented as the mean ± SD. *P < 0.05, **P < 0.01 versus the control group; #P < 0.05, ##P < 0.01 versus the MET NVB+ Endo group